CPHA Canvax

"The primary objective of this statement is to review the evidence on the effectiveness and safety of additional dose(s) of MMR vaccine when provided in mumps outbreak settings, including the off-label administration of a third dose of MMR vaccine (MMR3) in individuals who were previously vaccinated with two valid doses. A literature and environmental evidence review was undertaken to develop recommendations for the use of additional dose(s) of MMR vaccine in mumps outbreak settings." - Public Health Agency of Canada 


Related Resources


Implementation Tool



Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Outbreak and Crisis Management,Outbreak and Pandemic Planning,Vaccine Preventable Diseases,Communicable Diseases,Measles,Mumps,Rubella,Vaccine Safety and Development,Research and Development,Vaccine Effectiveness and Efficacy Program Planning and Delivery
Program Delivery and Evaluation
Outbreak and Crisis Management
Outbreak and Pandemic Planning
Vaccine Preventable Diseases
Communicable Diseases
Vaccine Safety and Development
Research and Development
Vaccine Effectiveness and Efficacy


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.